miR-103/107 modulates multidrug resistance in human gastric carcinoma by downregulating Cav-1

Lipid raft modulation by Rp1 reverses multidrug resistance via inactivating MDR-1 and Src inhibition

(2013) Un-Jung Yun et al.   BIOCHEMICAL PHARMACOLOGY

P-glycoprotein Inhibition as a Therapeutic Approach for Overcoming Multidrug Resistance in Cancer: Current Status and Future Perspectives

(2013) Ziyad Binkhathlan et al.   CURRENT CANCER DRUG TARGETS

Function of miRNA in Controlling Drug Resistance of Human Cancers

(2013) Liu Hong et al.   CURRENT DRUG TARGETS

Mechanisms of Drug Resistance in Cancer Chemotherapy: Coordinated Role and Regulation of Efflux Transporters and Metabolizing Enzymes

(2013) Ramya Vadlapatla et al.   CURRENT PHARMACEUTICAL DESIGN

The Role of E3 Ubiquitin Ligase Cbl Proteins in β-Elemene Reversing Multi-Drug Resistance of Human Gastric Adenocarcinoma Cells

(2013) Ye Zhang et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Inherent and Acquired Resistance to Paclitaxel in Hepatocellular Carcinoma: Molecular Events Involved

(2013) Avtar Singh Meena et al.   PLoS One

MUC1 induces drug resistance in pancreatic cancer cells via upregulation of multidrug resistance genes

(2013) S Nath et al.   Oncogenesis

miR-181a sensitizes a multidrug-resistant leukemia cell line K562/A02 to daunorubicin by targeting BCL-2

(2012) H. Li et al.   ACTA BIOCHIMICA ET BIOPHYSICA SINICA

Current questions for the treatment of advanced gastric cancer

(2012) A. Cervantes et al.   CANCER TREATMENT REVIEWS

Emerging Roles for Modulation of microRNA Signatures in Cancer Chemoprevention

(2012) K. Neelakandan et al.   CURRENT CANCER DRUG TARGETS

Collateral sensitivity as a strategy against cancer multidrug resistance

(2012) Kristen M. Pluchino et al.   DRUG RESISTANCE UPDATES

MicroRNA-21 Inhibitor Sensitizes Human Glioblastoma U251 Stem Cells to Chemotherapeutic Drug Temozolomide

(2012) Shuguang Zhang et al.   JOURNAL OF MOLECULAR NEUROSCIENCE

β-Elemene-induced autophagy protects human gastric cancer cells from undergoing apoptosis

(2011) Jing Liu et al.   BMC CANCER

Down-regulation of microRNA-200c is associated with drug resistance in human breast cancer

(2011) Junqing Chen et al.   MEDICAL ONCOLOGY

miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2

(2011) Wei Zhu et al.   MEDICAL ONCOLOGY

miR-1915 inhibits Bcl-2 to modulate multidrug resistance by increasing drug-sensitivity in human colorectal carcinoma cells

(2011) Ke Xu et al.   MOLECULAR CARCINOGENESIS

MicroRNAs 103 and 107 regulate insulin sensitivity

(2011) Mirko Trajkovski et al.   NATURE

Metformin inhibits P-glycoprotein expression via the NF-κB pathway and CRE transcriptional activity through AMPK activation

(2010) Hyung Gyun Kim et al.   BRITISH JOURNAL OF PHARMACOLOGY

RNA interference-directed caveolin-1 knockdown sensitizes SN12CPM6 cells to doxorubicin-induced apoptosis and reduces lung metastasis

(2010) Juwon Park et al.   TUMOR BIOLOGY

Reversal of P-glycoprotein-mediated multi-drug resistance by the E3 ubiquitin ligase Cbl-b in human gastric adenocarcinoma cells

(2009) Ye Zhang et al.   JOURNAL OF PATHOLOGY

Longitudinal effects of thymidine analogues on mtDNA, mtRNA and multidrug resistance (MDR-1) induction in cultured cells

(2008) E. Papp et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Doxorubicin activates FOXO3a to induce the expression of multidrug resistance gene ABCB1 (MDR1) in K562 leukemic cells

(2008) R. C-Y. Hui et al.   MOLECULAR CANCER THERAPEUTICS

Caveolin-1 expression is significantly associated with drug resistance and poor prognosis in advanced non-small cell lung cancer patients treated with gemcitabine-based chemotherapy

(2007) Chao-Chi Ho et al.   LUNG CANCER